Mona Motwani

3.0k citations
32 papers · 1.8k indexed · 1 hit paper · h-index 14
Topics
interferon and immune responses (4 papers)Cancer-related Molecular Pathways (4 papers)Lung Cancer Research Studies (3 papers)
Partner nations
United StatesFranceChina

In The Last Decade

Mona Motwani

31 papers receiving 1.8k citations

Hit Papers

DNA sensing by the cGAS–STING pathway in health and disease201920262021202320192505007501000

Peers

Mona Motwani
Comparison fields: 5 of 98
  • Molecular Biology 1.1k
  • Immunology 995
  • Oncology 446
  • Infectious Diseases 300
  • Cancer Research 232
Replace Evangelia Komisopoulou with:
Evangelia Komisopoulou United States
Bin Yuan United States
Martin K. Thomsen Denmark
Wen-Shuz Yeow United States
Andrew L. Snow United States
Sandy Der Canada
Xuewu Zhang China
Partha S. Chowdhury United States
Susana Orozco United States
Jaromir Vlach United States
Mona Motwani relative to Evangelia Komisopoulou United States Evangelia Komisopoulou's profile →
Citations per field
00.5×
Evangelia Komisopoulou · 1×
Citations per year

Countries citing papers authored by Mona Motwani

Since Specialization
Citations

This map shows the geographic impact of Mona Motwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Motwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Motwani more than expected).

Fields of papers citing papers by Mona Motwani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Motwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Motwani. The network helps show where Mona Motwani may publish in the future.

Co-authorship network of co-authors of Mona Motwani

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Motwani. A scholar is included among the top collaborators of Mona Motwani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Motwani. Mona Motwani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 9
3 19
4 48
5 3
6 99
7 2
8
DNA sensing by the cGAS–STING pathway in health and diseasebreakdown →
1045
9 72
10 4
11 13
12 12
13 29
14 15
15 32
16 34
17 6
18 5
19
Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.
40
20 15

About Mona Motwani

Mona Motwani is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include interferon and immune responses (4 papers), Cancer-related Molecular Pathways (4 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Immunology (995 citations), Oncology (446 citations) and Infectious Diseases (300 citations). Mona Motwani has collaborated with scholars based in United States, France and China. Frequent co-authors include Katherine A. Fitzgerald, Gary K. Schwartz, Thomas Delohery, Ann Marshak‐Rothstein, Rakesh Kumar, Xiaoling Li, Sudesh Pawaria, Terry Fang, Linda C. Burkly and Ning Guo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026